What is the current size and expected growth rate of the immunoassays market?

The immunoassays market stands at USD 35.61 billion in 2025 and is projected to reach USD 45.42 billion by 2030, advancing at a 4.99% CAGR. Read More

Which product category contributes the largest share of revenue?

Reagents and kits account for 64.34% of 2024 revenue, reflecting recurring demand across routine and specialty testing. Read More

Why are chemiluminescence immunoassays attracting more laboratories?

CLIA platforms deliver higher analytical sensitivity and faster turnaround than traditional ELISA, supporting applications such as therapeutic-drug monitoring and oncology biomarker detection. Read More

Which region is expected to register the fastest growth through 2030?

Asia-Pacific will post the highest regional CAGR at 5.54%, driven by healthcare infrastructure upgrades in China, India, and Japan. Read More

What are the main restraints facing market participants today?

Stringent multi-jurisdictional regulatory approvals, high capital costs for automated systems, cross-reactivity challenges, and antibody-supply bottlenecks slow product rollout and adoption. Read More

How will point-of-care testing influence future demand?

Decentralized and home-based rapid tests are projected to grow at a 5.53% CAGR, expanding market reach and fueling demand for compact, AI-enabled analyzers. Read More

Immunoassays Companies

This report lists the top Immunoassays companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Immunoassays industry.

About This Report
- Market Size & Share
- Market Analysis
- Trends and Insights
- Segment Analysis
- Geography Analysis
- Competitive Landscape
- Major Players
- Recent Developments
Table of Contents
SCOPE OF THE REPORT
Market Definition